Drug Shortage Report for SODIUM PHOSPHATES INJECTION USP

Last updated on 2021-09-15 History
Report ID 143043
Drug Identification Number 00896187
Brand name SODIUM PHOSPHATES INJECTION USP
Common or Proper name SODIUM PHOSPHATES
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) SODIUM PHOSPHATE DIBASIC SODIUM PHOSPHATE MONOBASIC
Strength(s) 268MG 276MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 X 10ML
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2021-07-26
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-09-15
Company comments This product is on allocation at 50% of historical usage
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-09-15 French Compare
v8 2021-09-15 English Compare
v7 2021-09-14 French Compare
v6 2021-09-14 English Compare
v5 2021-07-27 English Compare
v4 2021-07-26 French Compare
v3 2021-07-26 English Compare
v2 2021-07-26 French Compare
v1 2021-07-26 English Compare